Yifan Pharmaceuticals: Prostaglandin Injection Obtains Registration Approval in Tajikistan

On the evening of August 27th, Yifan Medicine announced that its wholly-owned subsidiary, SciGen Pte.Ltd., received an approval from the Ministry of Health and Social Protection of Tajikistan on August 26th to market and sell their pharmaceutical product, Oxytocin Injection, in Tajikistan.